Tech Company Financing Transactions
Sonexa Therapeutics Funding Round
On 1/31/2008, Sonexa Therapeutics announced $30 million in Series A funding from Domain Associates, Alta Partners and Scale Venture Partners.
Transaction Overview
Company Name
Announced On
1/31/2008
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors
Domain Associates (Lead Investor) (Eckard Weber)
Alta Partners (Robert Alexander)
Scale Venture Partners (Lou Bock)
Proceeds Purpose
Proceeds from the financing will be used to fund the licensing anddevelopment of a novel drug being tested as a therapeutic to treat Alzheimer'sdisease. Sonexa has licensed worldwide, exclusive rights (except for Japan andcertain Asian countries) to the compound from a Japanese pharmaceuticalcompany. Human trials in the US are scheduled to begin February '08.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12481 High Bluff Dr. 150
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
The company is developing treatments for Alzheimer's disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eckard Weber
Chief Financial Officer
Lynne Rollins
Chief Medical Officer
Martin Koller
VP - R & D
Tilman Oltersdorf
VP - Regulatory Affairs
Barbara Finn
Browse more venture capital transactions:
Prev: 1/31/2008: GreenRoad venture capital transaction
Next: 1/31/2008: Ensenda venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs